Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Jiedu Huayu Granules (扶正解毒化瘀颗粒) is a traditional Chinese medicine (TCM) preparation based on the "Fuzheng Jiedu Huayu" principle, which translates to "supporting healthy qi, detoxifying, and resolving stasis." This formula is widely used in China as an adjunctive therapy for various conditions, including cancer and infections. Its main therapeutic effects are to support immune function ("supporting healthy qi"), clear toxins ("detoxifying"), and resolve blood stasis ("resolving stasis"). In oncology, it is used alongside modern therapies such as chemotherapy, radiotherapy, targeted therapy, and immunotherapy to reduce toxicity and enhance efficacy. It has also been studied for its role in treating pneumonia in elderly patients[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuzheng Jiedu Huayu Granules.